Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy

Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy

With an expected incidence of more than 1 million cases by 2025, liver cancer remains a problem for world health. With over 90% of cases, hepatocellular carcinoma (HCC) is the most prevalent kind of liver cancer. In this review, we presented the range of experimental therapeutics for patients with a...

Full description

Bibliographic Details
Main Authors: Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, Parastoo Fooladpanjeh, Neda Faal Hamedanchi, Nima Broomand Lomer, Arian Karimi Rouzbahani, Mohammad Reza Naimi-Jamal
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Livers
Subjects:
hepatocellular carcinoma
unresectable treatment
chemotherapy
targeted therapy
Online Access:https://www.mdpi.com/2673-4389/3/1/11

Internet

https://www.mdpi.com/2673-4389/3/1/11

Similar Items